Klaus H. Beiske

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Erratum: Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 16, 2026

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Frequency and Prognostic Significance of Genetic Abnormalities in a Subgroup of Patients With Intermediate-Risk Neuroblastoma: A SIOPEN Study.

Journal: JCO precision oncology

Published: July 01, 2026

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Mutated FGFR1 is an oncogenic driver and therapeutic target in high-risk neuroblastoma.

Journal: The Journal of clinical investigation

Published: February 12, 2026

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas.

Journal: Leukemia

Published: November 13, 2025

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP Study.

Journal: The American journal of surgical pathology

Published: October 28, 2025

International neuroblastoma risk group consortium: a model of a networking for rare cancers.

International neuroblastoma risk group consortium: a model of a networking for rare cancers.

Journal: Journal of the National Cancer Institute

Published: June 22, 2025

International neuroblastoma risk group consortium: a model of networking for rare cancers.

International neuroblastoma risk group consortium: a model of networking for rare cancers.

Journal: Journal of the National Cancer Institute

Published: June 22, 2025

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Harmonization of Reporting of ALK Genetic Alterations in Neuroblastoma: A SIOPEN Biology Study.

Journal: The Journal of molecular diagnostics : JMD

Published: April 08, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: medRxiv : the preprint server for health sciences

Published: March 31, 2025

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

Journal: Blood advances

Published: March 26, 2025

Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR).

Data set for reporting of peripheral neuroblastic tumours: recommendations from the international collaboration on cancer reporting (ICCR).

Journal: Histopathology

Published: February 24, 2025

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Biomarker-adapted treatment in high-risk large B-cell lymphoma.

Journal: HemaSphere

Published: November 29, 2024

Showing 1-12 of 70

Last Updated: 09/26/2026